Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Proxy Solicitation & Information Statement 2021

Dec 13, 2021

51201_rns_2021-12-13_dd0c035a-8fc6-4e60-b1d8-531f09776418.pdf

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

==> picture [45 x 45] intentionally omitted <==

==> picture [59 x 14] intentionally omitted <==

SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. (深圳市海普瑞藥業集團股份有限公司)

(A joint stock company incorporated in the People’s Republic of China with limited liability) (Stock code: 9989)

PROXY FORM

FOR THE 2022 FIRST EXTRAORDINARY GENERAL MEETING TO BE HELD ON TUESDAY, 4 JANUARY 2022 (OR ANY ADJOURNMENT THEREOF)

I/We [(Note 1)] of [(Note 2)] being the registered holder(s) of [(Note 3)] H shares of RMB1.00 each in the share capital of Shenzhen Hepalink Pharmaceutical Group Co., Ltd . (the “ Company ”), hereby appoint the Chairman of the meeting [(Notes 4 and 5)] or of (address)

to act as my/our proxy to attend and vote for me/us and on my/our behalf at the 2022 first extraordinary general meeting (the “ EGM ”) of the Company to be held at 2:30 p.m. on Tuesday, 4 January 2022 at Ballroom, 2/F, L’Hermitage Hotel, 3031 Nanhai Boulevard, Nanshan District, Shenzhen, the People’s Republic of China (the “ PRC ”) and at any adjournment thereof for the purposes of considering and, if thought fit, passing the resolution set out in the circular and notice (the “ Notice ”) of the Company dated 13 December 2021 regarding the EGM and to exercise all rights conferred on proxies under laws, regulations and the articles of association of the Company in respect of the resolution set out in the Notice as hereunder, or if no such indication is given, as my/our proxy thinks fit.

SPECIAL RESOLUTION FOR(Note 6) AGAINST(Note 6) ABSTAIN(Note 6)
To consider and approve the proposed issuance of corporate bonds in the
PRC by the Company, and to authorise Mr. Li Li, chairman of the board of
directors of the Company, and any person authorised by him to deal with
the relevant matters (details of this resolution were set out in the notice of
EGM dated 13 December 2021)

Date:

Signature(s) [(Note 7)] :

Notes:

  1. Please insert full name(s) in BLOCK CAPITALS .

  2. Please insert full address(es) in BLOCK CAPITALS .

  3. Please insert the number of H shares registered in your name(s) to which this proxy form relates. If no number of shares is inserted, this proxy form will be deemed to relate to all H shares of the Company registered in your name(s).

  4. If you are a Shareholder who is entitled to attend and vote at the meeting, you are entitled to appoint one or more proxies to attend instead of you and to vote on your behalf. A proxy needs not be a Shareholder of the Company, but must attend the meeting in person in order to represent you.

  5. If any proxy other than the Chairman of the meeting is preferred, please strike out the words “the Chairman of the meeting” and insert the full name and address of the proxy (or proxies) desired in the space provided. If no name is inserted, the Chairman of the meeting will act as your proxy. ANY ALTERATION MADE TO THIS PROXY FORM MUST BE INITIALLED BY THE PERSON(S) WHO SIGNS IT.

  6. IMPORTANT: IF YOU WISH TO VOTE FOR THE RESOLUTION, TICK () IN THE BOX BELOW THE BOX MARKED “FOR”. IF YOU WISH TO VOTE AGAINST THE RESOLUTION, TICK () IN THE BOX BELOW THE BOX MARKED “AGAINST”. IF YOU WISH TO ABSTAIN, TICK () IN THE BOX BELOW THE BOX MARKED “ABSTAIN”. If you return this proxy form without indicating as to how your proxy is to vote on any particular matter, the person appointed as your proxy will exercise his/her discretion as to whether he/she votes and, if so, how and, unless instructed otherwise, he/she may also vote or abstain from voting as he/she thinks fit on any other business (including amendments to the resolution) that may be proposed at the meeting. The shares abstained will be counted in the calculation of the required majority.

  7. This proxy form must be signed and dated by the Shareholder or his/her attorney duly authorized in writing. If the Shareholder is a company, it should execute this proxy form under its common seal or by its directors or (a) person(s) duly authorized to sign on its behalf. In case of joint holders, only the person whose name stands first on the register of members may attend and vote at the EGM, either in person or by proxy.

  8. To be valid, this proxy form, together with the power of attorney or other authority, if any, under which it is signed, or a notary certified copy of such power of attorney or authority, must be completed and deposited at the H share registrar of the Company, Tricor Investor Services Limited, at Level 54, Hopewell Centre, 183 Queen’s Road East, Hong Kong (for holders of H shares), or at the Company’s headquarters in the PRC, at No. 21 Langshan Road, Nanshan District, Shenzhen, the PRC (for holders of A shares), not less than 24 hours before the meeting or any adjournment thereof.

  9. Completion and return of this proxy form will not preclude you from attending and voting at the meeting in person if you so wish.

  10. Shareholders or their proxies attending the meeting shall produce their identity documents.